InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Browse the complete record of transactions filed by BIZZARI JEAN-PIERRE, Director. Officer active across 1 companies, notably Halozyme Therapeutics, INC.. In total, 5 disclosures have been published. Total volume traded: €2.4m. The latest transaction was filed on 5 May 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations5 total
06,206 shares0
Restricted Stock Units
SEC:0001179110-22-002906:0·
€1m35,000 shares@ €34.83230.015% mcap100.0% of flow
Common Stock
SEC:0001179110-21-008418·
€1m35,000 shares@ €34.83230.015% mcap50.0% of flow
Common Stock
SEC:0001179110-21-008418:0·
5,230 shares
Restricted Stock Units
SEC:0001179110-21-004969·
05,230 shares0
Restricted Stock Units
SEC:0001179110-21-004969:0·
5 of 5 declarations
About BIZZARI JEAN-PIERRE
Jean-Pierre Bizzari is a Director at Halozyme Therapeutics, Inc. He brings valuable expertise in corporate governance and business strategy. His role involves overseeing the company's operations and contributing to strategic decision-making. With a strong background in the biopharmaceutical sector, he is involved in developing innovative solutions to improve patient health.
